$165 Million is the total value of Antipodean Advisors LLC's 20 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 28.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MDCO | Sell | MEDICINES CO | $15,713,000 | -31.5% | 467,223 | -35.3% | 9.50% | -8.7% |
| SLV | Sell | ISHARES SILVER TRUSTishares | $15,185,000 | -12.6% | 850,000 | -28.1% | 9.18% | +16.6% |
| GRA | Sell | GRACE W R & CO DEL NEW | $14,056,000 | -61.8% | 192,000 | -62.9% | 8.50% | -49.1% |
| DLTR | Sell | DOLLAR TREE INC | $11,403,000 | -42.9% | 121,000 | -50.0% | 6.89% | -23.8% |
| SEM | Sell | SELECT MED HLDGS CORP | $11,390,000 | -26.4% | 1,047,828 | -20.0% | 6.89% | -1.8% |
| GLD | Sell | SPDR GOLD TRUST | $11,256,000 | -1.4% | 89,000 | -8.2% | 6.80% | +31.5% |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $7,176,000 | -64.7% | 523,000 | -50.7% | 4.34% | -53.0% |
| STZ | Sell | CONSTELLATION BRANDS INCcl a | $6,417,000 | -67.8% | 38,797 | -70.6% | 3.88% | -57.1% |
| INSYQ | Sell | INSYS THERAPEUTICS INC NEW | $3,951,000 | -27.8% | 305,294 | -10.8% | 2.39% | -3.7% |
| SHLDQ | Sell | SEARS HLDGS CORP | $3,675,000 | -27.7% | 270,000 | -18.7% | 2.22% | -3.6% |
| GCP | Exit | GCP APPLIED TECHNOLOGIES INC | $0 | – | -135,000 | -100.0% | -1.22% | – |
| GOOGL | Exit | ALPHABET INCcap stk cl a | $0 | – | -8,500 | -100.0% | -2.94% | – |
| AGNC | Exit | AMERICAN CAPITAL AGENCY CORP | $0 | – | -419,000 | -100.0% | -3.54% | – |
| FB | Exit | FACEBOOK INCcl a | $0 | – | -118,000 | -100.0% | -6.10% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CARVANA CO | 21 | Q2 2023 | 38.5% |
| AMAZON COM INC | 20 | Q4 2020 | 33.8% |
| SEA LTD | 19 | Q3 2023 | 60.8% |
| CARDLYTICS INC | 18 | Q3 2023 | 26.3% |
| MEDICINES CO | 18 | Q4 2019 | 19.8% |
| ATARA BIOTHERAPEUTICS INC | 15 | Q3 2023 | 17.9% |
| CONSTELLATION BRANDS INC | 14 | Q4 2016 | 11.1% |
| HERBALIFE NUTRITION LTD | 13 | Q1 2021 | 24.8% |
| CLARIVATE PLC | 11 | Q4 2021 | 24.4% |
| EXACT SCIENCES CORP | 11 | Q2 2019 | 24.6% |
View Antipodean Advisors LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Oncothyreon Inc.Sold out | January 09, 2013 | 0 | 0.0% |
View Antipodean Advisors LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
View Antipodean Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.